• Revenues Increase 248% in third quarter 2020 vs. 2019
  • Company reaches profitability in the third quarter

Lake Forest , Calif, Nov. 09, 2020 (GLOBE NEWSWIRE) -- ToughBuilt Industries, Inc. (“ToughBuilt®” or the “Company”) (NASDAQ: TBLT; TBLTW) announced today its unaudited financial results for the third quarter and nine-months ended September 30, 2020.

Operating Results for the Three Months Ended September 30, 2020

 Net sales for three-month period ended September 30, 2020 were $16.6 million, an increase of 248% from $4.7 million for the same period in 2019.
 Gross profit increased by 410% to $7.5 million for the three months ended Sept 30, 2020, from $1.4 million in the same period in 2019.
 Income from operations for the three months ended Sept 30, 2020 was $335,000, compared to a loss of $2.4 million for the same period in 2019.
      Net Income was $120,000 for the three months ended Sept 30, 2020, compared to a net loss of $2.6 million in the same period in 2019.

Operating Results for the Nine Months Ended September 30, 2020

 Net sales for the nine-month period ended Sept 30, 2020 were $27.4 million, an increase of 88% from $14.5 million for the same period in 2019.
 Gross profit increased by 203% to $11.6 million in the nine months ended Sept 30, 2020, from $3.8 million for the same period in 2019.
 Loss from operations for the nine months ended Sept 30, 2020 was $5.3 million, compared to a loss of $6.4 million for the same period in 2019.
      Net loss for the nine-month period ended Sept 30, 2020 was $6.1 million, compared to a net loss of $2.1 million for the same period in 2019.

Michael Panosian, ToughBuilt’s Chief Executive Officer, commented, “ToughBuilt delivered record financial results across the board, despite the Covid-19 pandemic impacting the industry globally. I am proud of our tough team and grateful to all retail partners, international manufacturers and global distributors for their amazing support and efforts. We continue to navigate today’s complex business landscape and are encouraged to implement more development and growth in all Markets.”

“During the third quarter, we increased our inventory levels to ensure timely delivery of products, increased our product pipeline, expanded our customer and manufacturing relationships internationally and utilized our storefront to create more brand awareness and sales to service our end users. We remain committed and confident to providing market-leading innovative quality products for the professionals and other passionate builders.”


ToughBuilt Industries, Inc. is an advanced product design, manufacturer and distributor with emphasis on innovative products. Currently focused on tools and other accessories for the professional and do-it-yourself construction industries, the Company markets and distributes various home improvement and construction product lines for both the do-it-yourself (DIY) and professional markets within the global multibillion dollar per year tool market industry under the TOUGHBUILT™ brand name. The Company’s products are designed in-house. The Company’s current product line includes three major categories, with several additional categories in various stages of development, consisting of Soft Goods & Kneepads and Sawhorses & Work Products. The Company’s mission is to provide innovative and superior quality-products to the building and home improvement communities derived in part from enlightened creativity for our end users while enhancing performance, improving well-being and building high brand loyalty. Additional information about the Company is available at:


This press release contains “forward-looking statements.” Such statements may be preceded by the words “intends,” “may,” “will,” “plans,” “expects,” “anticipates,” “projects,” “predicts,” “estimates,” “aims,” “believes,” “hopes,” “potential” or similar words. Forward-looking statements are not guarantees of future performance, are based on certain assumptions and are subject to various known and unknown risks and uncertainties, many of which are beyond the Company’s control, and cannot be predicted or quantified and consequently, actual results may differ materially from those expressed or implied by such forward-looking statements. Such risks and uncertainties include, without limitation, risks and uncertainties associated with (i) market acceptance of our existing and new products, (ii) delays in bringing products to key markets, (iii) an inability to secure regulatory approvals for the ability to sell our products in certain markets, (iv) intense competition in the industry from much larger, multinational companies, (v) product liability claims, (vi) product malfunctions, (vii) our limited manufacturing capabilities and reliance on subcontractors for assistance, (viii) our efforts to successfully obtain and maintain intellectual property protection covering our products, which may not be successful, (ix) our reliance on single suppliers for certain product components, (x) the fact that we will need to raise additional capital to meet our business requirements in the future and that such capital raising may be costly, dilutive or difficult to obtain and (xi) the fact that we conduct business in multiple foreign jurisdictions, exposing us to foreign currency exchange rate fluctuations, logistical and communications challenges, burdens and costs of compliance with foreign laws and political and economic instability in each jurisdiction. More detailed information about the Company and the risk factors that may affect the realization of forward looking statements is set forth in the Company’s filings with the Securities and Exchange Commission (SEC), including the Company’s Annual Report on Form 10-K, Quarterly Reports on Form 10-Q and Current Reports on Form 8-K. Investors and security holders are urged to read these documents free of charge on the SEC’s web site at The Company assumes no obligation to publicly update or revise its forward-looking statements as a result of new information, future events or otherwise.

Investor Relations Contact:
Andrew J. Barwicki
Investor Relations
Tel: 516-662-9461


  September 30,  December 31, 
  2020  2019 
Current Assets        
Cash $8,891,612  $25,063 
Accounts receivable  12,584,296   2,075,380 
Factor receivables, net  2,107,082   174,042 
Inventory  6,684,030   2,215,497 
Prepaid assets  1,045,210   254,070 
Note receivable  1,480,000   4,480,000 
Total Current Assets  32,792,230   9,224,052 
Other Assets        
Property and equipment, net  2,352,561   1,029,885 
Other assets  221,168   215,688 
Total Assets $35,365,959  $10,469,625 
Liabilities and Shareholders’ Equity        
Current Liabilities        
Accounts payable $5,508,639  $2,536,871 
Accrued expenses  548,066   364,309 
Factor loan payable  1,513,885   125,645 
Convertible notes payable, net of discount  1,945,065   4,216,307 
Total Current Liabilities  9,515,655   7,243,132 
Total Liabilities  9,515,655   7,243,132 
Commitment and Contingencies (Note 5)        
Shareholders’ Equity        
Series D Preferred Stock, $1,000 par value, 5,775 shares authorized, 0 and 5,775 issued, and outstanding at September 30, 2020 and December 31, 2019, respectively. Liquidation preference of $5,775,000 at December 31, 2019.  -   4,816,485 
Common stock, $0.0001 par value, 200,000,000 shares authorized, 38,414,631 and 3,300,015 shares issued and outstanding at September 30, 2020 and December 31, 2019, respectively  3,842   330 
Additional paid-in capital  75,412,814   41,823,048 
Accumulated deficit  (49,566,352)  (43,413,370)
Total Shareholders’ Equity  25,850,304   3,226,493 
Total Liabilities and Shareholders’ Equity $35,365,959  $10,469,625 


  Three Months Ended September 30,  Nine Months Ended September 30, 
  2020  2019  2020  2019 
Revenues, net of allowances                
Metal goods $5,368,015  $2,527,734  $10,824,861  $6,443,984 
Soft goods  11,295,374   2,256,353   16,587,686   8,116,914 
Total revenues, net of allowances  16,663,389   4,784,087   27,412,547   14,560,898 
Cost of Goods Sold                
Metal goods  2,906,559   1,759,091   6,559,020   4,733,524 
Soft goods  6,207,533   1,545,027   9,225,444   5,992,769 
Total cost of goods sold  9,114,092   3,304,118   15,784,464   10,726,293 
Gross profit  7,549,297   1,479,969   11,628,083   3,834,605 
Operating expenses:                
Selling, general and administrative expenses  6,423,593   3,549,480   15,480,432   8,807,483 
Research and development  789,890   391,460   1,496,129   1,521,503 
Total operating expenses  7,213,483   3,940,940   16,976,561   10,328,986 
Income (loss) from operations  335,814   (2,460,971)  (5,348,478)  (6,494,381)
Other income (expense)                
Interest expense  (214,979)  (288,152)  (804,504)  (456,689)
Change in fair value of warrant derivative  -   59,781   -   4,769,363 
Total other income (expense)  (214,979)  (228,371)  (804,504)  4,312,674 
Net income (loss) $120,835  $(2,689,342) $(6,152,982) $(2,181,707)
Redemption of Series D Preferred Stock deemed dividend  -   -   (1,295,294)  - 
Common stock deemed dividend  -   -   -   (2,137,190)
Net income (loss) attributable to common stockholders $120,835  $(2,689,342) $(7,488,276)  (4,318,897)
Basic and diluted net loss per share attributed to common stockholders                
Basic net loss per common share $0.00  $(0.87) $(0.32) $(2.27)
Basic weighted average common shares outstanding  38,414,631   3,084,456   23,154,481   1,906,179 
Diluted net loss per common share $0.00  $(0.87) $(0.32) $(2.27)
Diluted weighted average common shares outstanding  38,414,631   3,084,456   23,154,481   1,906,179 


  Nine Months Ended September 30, 
  2020  2019 
Cash flows from operating activities:        
Net income (loss) $(6,152,982) $(2,181,707)
Adjustments to reconcile from net income (loss) to net cash used in operating activities:        
Depreciation  394,322   157,652 
Amortization of debt discount and debt issuance cost  634,892   198,913 
Change in fair value of warrant derivative  -   (4,769,363)
Stock-based compensation expense  315,673   273,200 
Changes in operating assets and liabilities        
Accounts receivable, net  (10,508,916)  (689,042)
Factor receivables, net  (1,933,040)  597,871 
Inventory  (4,468,533)  (1,394,524)
Prepaid assets  (218,739)  7,486 
Other assets  (5,479)  (66,415)
Accounts payable  2,971,766   82,119 
Accrued expenses  183,757   (541,834)
Deferred revenue  -   (107,776)
Net cash used in operating activities  (18,787,279)  (8,433,420)
Cash flows from investing activities:        
Proceeds from note receivable  3,000,000   - 
Purchases of property and equipment  (1,716,998)  (651,795)
Net cash provided by (used in) investing activities  1,283,002   (651,795)
Cash flows from financing activities:        
Proceeds from sales of common stock and warrants, net of costs  28,122,740   - 
Proceeds from exercise of Series A warrants  -   2,172,680 
Proceeds from exercise of Placement Agent warrants  -   16,818 
Proceeds from note payable  -   4,515,000 
Proceeds from factor loan payable  1,388,240   - 
Repayments of factor loan payable      (623,844)
Repayments of Series D Preferred Stock  (3,140,154)  - 
Net cash provided by financing activities  26,370,826   6,080,654 
Net increase (decrease) increase in cash  8,866,549   (3,004,561)
Cash, beginning of period  25,063   5,459,884 
Cash, end of period $8,891,612  $2,455,323 
Supplemental disclosure of cash flow information:        
Cash paid during the period for:        
Interest $-  $- 
Income taxes $-  $800 
Supplemental disclosure of non-cash investing and financing activities:        
Cashless exercise of warrants $244  $- 
Issuance of warrants in connection with convertible notes payable $-  $575,000 
Debt issuance cost paid with warrants $-  $20,000 
Conversion of Series C Preferred Stock to common stock $13  $3,671,024 
Conversion of convertible notes payable to common stock $2,906,134  $- 
Conversation of Series D Preferred Stock to common stock $2,971,311  $- 
Issuance of common stock for prepaid services $572,400  $- 
Restricted promissory note in connection with convertible notes payable $-  $4,780,000 
Original issue discount $-  $1,720,000 
Conversion of Series B warrants into common stock $-  $14,584,371